HUYABIO International
Sungwoo Ahn has held various business development and regulatory science roles in companies such as HUYABIO International and YUHAN USA. With experience in licensing, investment opportunities, and strategic partnership deal sourcing in the biotech/pharmaceutical sector. Also served as an instructor at San Diego State University and has a background in molecular biology and sociology of science and technology.
HUYABIO International
HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.